187 related articles for article (PubMed ID: 8189554)
1. Proto-oncogenes and tumor suppressor genes in human urological malignancies.
Strohmeyer TG; Slamon DJ
J Urol; 1994 Jun; 151(6):1479-97. PubMed ID: 8189554
[No Abstract] [Full Text] [Related]
2. Tumour suppressor genes in urinary tract oncology.
Brewster SF; Gingell JC; Brown KW
Br J Urol; 1992 Dec; 70(6):585-90. PubMed ID: 1336697
[No Abstract] [Full Text] [Related]
3. Molecular and cytogenetic events in urologic tumors.
Klein EA; Fair WR; Chaganti RS
Semin Urol; 1988 Feb; 6(1):2-21. PubMed ID: 2838875
[No Abstract] [Full Text] [Related]
4. Reviews on chromosome studies in urological tumors. I. Renal tumors.
Meloni AM; Bridge J; Sandberg AA
J Urol; 1992 Aug; 148(2 Pt 1):253-65. PubMed ID: 1321916
[No Abstract] [Full Text] [Related]
5. Inherited renal neoplasms.
Torres VE; Bjornsson J; Zincke H
J Nephrol; 1998; 11(5):229-38. PubMed ID: 9831235
[TBL] [Abstract][Full Text] [Related]
6. Molecular biology of testicular germ cell tumors: current status.
Schmidt B; Ackermann R; Strohmeyer T
J Mol Med (Berl); 1995 Jul; 73(7):355-67. PubMed ID: 8520968
[No Abstract] [Full Text] [Related]
7. Genetics in urogenital cancer.
Lynch HT; Walzak MP
Urol Clin North Am; 1980 Oct; 7(3):815-29. PubMed ID: 6256928
[No Abstract] [Full Text] [Related]
8. Absence of frameshift mutations in the bax gene in renal cell cancer (RCC) and transitional cell cancer (TCC).
Bilim VN; Kawasaki T; Takahashi K; Tomita Y
Anticancer Res; 1998; 18(3A):1655-9. PubMed ID: 9673385
[TBL] [Abstract][Full Text] [Related]
9. Approaches to proto-oncogene and tumour suppressor gene identification.
Patterson H
Eur J Cancer; 1992; 28(1):258-63. PubMed ID: 1314628
[No Abstract] [Full Text] [Related]
10. Biology and treatment of pediatric genitourinary tumors.
Geary ES; Gong MC; Shortliffe LM
Curr Opin Oncol; 1994 May; 6(3):292-300. PubMed ID: 8080859
[TBL] [Abstract][Full Text] [Related]
11. Closing in on another renal cancer suppressor locus near chromosome 3p14.
Kaye FJ
J Natl Cancer Inst; 1999 Sep; 91(18):1528-9. PubMed ID: 10491421
[No Abstract] [Full Text] [Related]
12. Cancer genetics: urological system. II.
Lynch HT
Nebr Med J; 1974 Dec; 59(12):460-5. PubMed ID: 4372563
[No Abstract] [Full Text] [Related]
13. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.
Hewitt SM; Hamada S; McDonnell TJ; Rauscher FJ; Saunders GF
Cancer Res; 1995 Nov; 55(22):5386-9. PubMed ID: 7585606
[TBL] [Abstract][Full Text] [Related]
14. The role of methylation in urological tumours.
van der Heijden AG
Arch Esp Urol; 2013 Jun; 66(5):432-9. PubMed ID: 23793761
[TBL] [Abstract][Full Text] [Related]
15. Absence of the L37P polymorphism in exon 1 of the CDKN2A gene.
Fung JJ; Liu L; Gao L; Monzon J; Lassam NJ; Hogg D
Mol Cell Probes; 1997 Jun; 11(3):231-2. PubMed ID: 9232623
[No Abstract] [Full Text] [Related]
16. [Antioncogenes in tumors in children].
Brugières L; Henry I; Junien C
Arch Fr Pediatr; 1990 Oct; 47(8):599-603. PubMed ID: 1964040
[No Abstract] [Full Text] [Related]
17. Molecular genetic parameters in pathogenesis and prognosis of testicular germ cell tumors.
Heidenreich A; Srivastava S; Moul JW; Hofmann R
Eur Urol; 2000 Feb; 37(2):121-35. PubMed ID: 10705188
[TBL] [Abstract][Full Text] [Related]
18. Expression of SET, an inhibitor of protein phosphatase 2A, in renal development and Wilms' tumor.
Carlson SG; Eng E; Kim EG; Perlman EJ; Copeland TD; Ballermann BJ
J Am Soc Nephrol; 1998 Oct; 9(10):1873-80. PubMed ID: 9773788
[TBL] [Abstract][Full Text] [Related]
19. Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.
Weidner U; Peter S; Strohmeyer T; Hussnätter R; Ackermann R; Sies H
Cancer Res; 1990 Aug; 50(15):4504-9. PubMed ID: 1973362
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology in nephrology: an overview with emphasis on the study of renal cancer.
Cohen HT; Sukhatme VP
Semin Nephrol; 1992 Nov; 12(6):495-505. PubMed ID: 1335610
[No Abstract] [Full Text] [Related]
[Next] [New Search]